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Synthetic peptideThe secondary structure, orientation and hydrogen/deuteriumexchange of SP-C33, a surfactant protein C analog,
in 1,2-dipalmitoyl-sn-glycero-3-phosphocholine/egg phosphatidylglycerol (8:2,wt./wt.) bilayers,was studiedby
attenuated total reﬂection Fourier transform infrared spectroscopy. This showed a transmembrane α-helix, in
which about 55% of the amide hydrogens do not exchange for up to 20 h. Moreover, C-terminally modiﬁed
SP-C33, either truncated after position 30, or having themethionine at position 31 exchanged for either lysine or
isoleucine, showed the same secondary structure and orientation. The different peptides, suspended in 1,2-
dipalmitoyl-sn-glycero-3-phosphocholine/1-palmitoyl-2-oleoyl-sn-glycero-3-phosphoglycerol 68:31 (wt./wt.),
were tested for surfactant activity in vitro in a captive bubble surfactometer and in vivo in an animal model of
respiratory distress syndrome using premature rabbit fetuses. All preparations showed similar surface activity in
the captive bubble surfactometer. Also, in the rabbit model, all preparations performed equally well and
signiﬁcantly better than non-treated controls, both regarding tidal volumes and lung gas volumes. Thus,
truncation or residue replacements in the C-terminal part of SP-C33 do not seem to affectmembrane association
or surfactant activity.r; DPPC, 1,2-dipalmitoyl-sn-
reﬂection Fourier transform
itive end expiratory pressure;
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The complex lipid/protein mixture of pulmonary surfactant
reduces the surface tension at the alveolar air–liquid interface to
near-zero values and thereby prevents the alveoli from collapsing at
exhalation. Lack of active surfactant is associated with respiratory
distress syndrome (RDS) which is common in premature babies.
Surfactant consists of several components with different functional
properties [1,2]. The main component, 1,2-dipalmitoyl-sn-glycero-3-
phosphocholine (DPPC), is responsible for surface tension reduction
but is dependent on more ﬂuid phospholipids and the hydrophobic
surfactant speciﬁc proteins (SP-) SP-B and SP-C to rapidly adsorb to
the air/liquid interface [3,4]. Both SP-B and SP-C are required for
establishment of alveolar patency at end-expiration [5].SP-C contains 35 residues with a random coil N-terminal segment
and a middle/C-terminal transmembrane α-helix which is rich in
valines. In spite of its rather simple structure, chemical synthesis of SP-C
is complicated by the propensity of valine to form β-sheets instead of
α-helices [6]. SP-C therefore is ametastable protein that tends to unfold
and turn into β-sheets [7,8]. Different approaches have been taken to
obtain SP-C analogs and we have previously designed the SP-C analog,
SP-C33, that has been shown to have surfactant properties similar to
native SP-C [9]. Differences of this peptide compared to human SP-C
includes removal of the two N-terminal amino acid residues, replace-
ment of the palmitoyl-Cys residues at positions 5 and 6 (positions 3 and
4 in SP-C33)with Ser, replacement of Leu 14 with Lys, and replacement
of the poly-valine part (positions 15–21 and 23–28) with poly-leucine.
The mechanism of SP-C action is not known, and several different
hypotheses have been discussed. It has been shown that SP-C disorders
the acyl chains of a phospholipid bilayer while the head groups are
stabilized, possibly due to its mobility gradient across the bilayer [10,11].
The mobility gradient is suggested to derive from interactions of a Lys–
Arg pair in the N-terminal end of the transmembrane α-helix with
phospholipidhead-groups and lack of residues in the C-terminal end that
are able to interactwith surrounding phospholipids. In the “squeeze-out”
hypothesis, SP-C is assumed to contribute to the process of removal of
non-DPPC lipids from the air/liquid interface upon overcompression [1].
SP-C is also thought to facilitate the reinsertion of surface active
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alveolar expansion [12].
In this study, we have examined the secondary structure, orienta-
tion, and dynamics of SP-C33 and how modiﬁcations of the C-terminal
end of SP-C33 affect the activity of a synthetic surfactant preparation.
Three different SP-C33 variants were studied. SP-C30 is a truncated
variant that is predicted to be too short to fully span a phospholipid
bilayer and thereby may obtain increased mobility. SP-C33M31K, in
which the methionine at position 31 has been exchanged with a lysine,
may anchor the C-terminal part of theα-helix in the bilayer and thereby
reduce its mobility gradient. SP-C33M31I, where the methionine at
position 31 was substituted with an isoleucine, is not expected to affect
mobility of the peptide.
2. Materials and methods
2.1. Lipids and peptides
DPPC and 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphoglycerol
(POPG) were obtained from Sigma Chemical (St. Louis, MO, USA).
SP-C33 (IPSSPVHLKRLKLLLLLLLLILLLILGALLMGL) was provided by
Chiesi Farmaceutici S.p.A (Parma, Italy).
SP-C33 M31K (IPSSPVHLKRLKLLLLLLLLILLLILGALLKGL), SP-C33
M31I (IPSSPVHLKRLKLLLLLLLLILLLILGALLIGL), and SP-C30
(IPSSPVHLKRLKLLLLLLLLILLLILGALL) were obtained from Thermo
Electron GmbH.
2.2. Surfactant preparations
DPPC/POPG (68:31, wt./wt.) was dissolved in chloroform/metha-
nol (1:1, vol./vol.) and mixed with either of the four SP-C analogs. The
peptide content in the preparations was 2% in relation to the
phospholipid weight. The solvents were evaporated under nitrogen
and the preparations were resuspended in normal saline to a ﬁnal
phospholipid concentration of 80 mg/ml by slow rotation at 37 °C. The
preparations were stored at −20 °C. Prior to examination of in vitro
surface activity, all solutions were diluted with saline to a ﬁnal
concentration of 10 mg phospholipids per milliliter.
For attenuated total reﬂection Fourier transform infrared (ATR-
FTIR) spectroscopy of the SP-C analogs in DPPC/PG (8:2, wt./wt.),
lipid/peptide mixtures in chloroform/methanol (lipid/peptide mass
ratio, 100:10 or 100:20) were evaporated under nitrogen and dried
under vacuum for 3 h. The lipid/peptide ﬁlms were then suspended in
5 mM HEPES buffer, pH 7.4. Lipid vesicles containing the peptides
were separated from unbound constituents by centrifugation in a 5%–
40% (wt./vol.) continuous sucrose gradient. The sucrose gradient was
fractioned and the proteoliposomes were detected by turbidity
measurement at 410 nm. To eliminate sucrose, the vesicles were
pelleted twice by ultracentrifugation and resuspended in 5 mMHEPES
buffer, pH 7.4.
2.3. Structure determination and hydrogen/deuterium (H/D) exchange
measurements
Structureandorientation of SP-C analogs inphospholipidmembrane
and H/D exchange for SP-C33 were obtained by ATR-FTIR spectroscopy
[13]. ATR-FTIR spectra were recorded at 20 °C on a Bruker IF-55
spectrometer (Ettlingen, Germany), equipped with a liquid nitrogen
cooled mercury cadmium telluride detector. The internal reﬂection
element was a germanium crystal (50×20×2 mm; ACM, Villiers St.
Frédéric, France) with an aperture angle of 45° yielding 25 internal
reﬂections. The samples were spread on the ATR element by slowly
evaporating the solvent under nitrogen. The spectra were recorded at a
nominal resolution of 2 cm−1 with 256 accumulations to improve the
signal/noise ratio. The secondary structure was determined from the
shape of the deuterated amide I band [14]. Brieﬂy, Fourier self-deconvolution was applied to detect the different secondary structure
components. To quantify the percentage of each resulting band, a least
square iterative curve-ﬁtting was performed to ﬁt Lorentzian line
shapes to the initial spectrum between 1700 and 1600 cm−1. The
percentage of each secondary structure was determined from the
Lorentzian band areas in the respective frequency region.
The orientation of SP-C analogs in a lipid bilayer was determined
from the orientation of the peptide bond C=O group as described
previously [14]. Additional spectra with parallel and perpendicular
polarized light with respect to the incidence plane were recorded. To
determine the α-helix orientation, a 27° deviation angle between the
α-helix axis and the C=O transition dipole moment was taken into
account. The mean angle between the helix axis and a normal to the
ATR plate was calculated from the dichroic ratio. The dichroic ratio
corresponding to the transition dipole moment of the γw(CH2) band
at 1200 cm−1 was used to characterize the lipid acyl chain orientation.
H/D exchange of accessible amide protons was obtained by
ﬂushing the sample on the ATR element with D2O saturated nitrogen
at room temperature. The decay of the NH-associated amide II band
area (1520–1580 cm−1) to lipid ν(C=O) band area was used to
monitor the H/D exchange in the amide group [14].
2.4. Circular dichroism (CD) spectroscopy
SP-C33 was dissolved in either methanol or in sodium dodecyl
sulfate (SDS) micelles in sodium phosphate buffer, pH 6.0, to a ﬁnal
concentration of 25 μM. CD spectra from 250 to 190 nm were
recorded in 1.0 mm path length quartz cuvettes using a J-810
spectropolarimeter (Jasco, Tokyo, Japan). The scan speed was
50 nm/min, response time was 2 s, and with an acquisition interval
of 0.5 nm and band width of 1 nm. The residual molar ellipticity (θ) is
expressed in kdeg×cm2×dmol−1. The α-helical content was calcu-
lated with the following equations: (θ208−4000/−37000)×100,
(θ222−3000/−39000)×100 [15].
2.5. In vitro surface activity measurements
Surface tension was measured in triplicates in an in vitro
simulation of the alveolus by a captive bubble surfactometer (CBS)
[16]. In the CBS, surfactant and an air-bubble representing the
alveolus are present in an air-tight enclosed chamber. To evaluate
surface activity under dynamic circumstances, the chamber is
compressed and surface tension can be calculated by studying the
shape and height/width ratio of the bubble.
In the experiment, 2 μl of the surfactant preparation (10 mg/ml)was
inserted into the sucrose-ﬁlled test chamber. After insertion, an air-
bubble was created and surface tension was measured during 5 min of
adsorption. In the followingquasi-static cycling experiments, the bubble
was compressed stepwise from the initial volume until a surface tension
less than 5 mN/m was reached, alternatively to a maximum area
compression of 50%, and then expandedduringﬁve cycles. For each run,
minimumandmaximumsurface tensions aswell as rate of compression
were registered and a median value was calculated.
2.6. In vivo experiments
To assess the surfactant activity of the different preparations in
vivo, preterm newborn rabbits obtained at a gestational age of 27 days
(term, 31 days) were used. The animals, randomly allocated to
different treatment groups, were anesthetized directly after birth,
tracheotomized, and then received one of the surfactant preparations
via a tracheal cannula. Surfactant, 80 mg/ml, was administered at a
dose of 2.5 ml/kg and non-treated animals served as negative
controls. The animals were kept in pletysmograph boxes at 37 °C
and ventilated in parallel with 100% oxygen at a frequency of 40 Hz
and an inspiration/expiration ratio of 1:1. The experiments were
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H2O. To open up the lungs, peak inspiratory pressure (PIP) was ﬁrst
set at 35 cm H2O for 1 min. Then, pressure was lowered to 28 cm H2O
for 2 min and further on to 23 cm H2O for 2 min, 18 cm H2O for
15 min, 13 cm H2O for 5 min, and 10 cm H2O for 5 min. Finally,
pressure was raised again to 18 cm H2O for 5 min, after which the
lungs were ventilated for additional 5 min with nitrogen to minimize
volume loss due to diffusion. Tidal volumes were recorded every
5 min during the experiment. At the end of the experiment, the
tracheal cannula was clamped at end expiration, the trachea was
ligated, and the lungs were excised and weighed. Lung gas volumes
were determined by water displacement technique [5,17].
2.7. Statistical analysis
Statistical differences were analyzed by one-way ANOVA followed
by Newman–Keuls multiple comparison test using GraphPad Prism 4
(GraphPad Software, La Jolla, CA, USA).
2.8. Ethical approval
Animal experiments were approved by the local ethical committee
for animal research, Stockholms Norra Djurförsöksetiska Nämnd
(205/04, 316/06).
3. Results
3.1. SP-C analogs secondary structure and orientation in a phospholipid
membrane
The structure of SP-C analogs reconstituted in a DPPC/PG (8:2, wt./
wt.) environment was determined by ATR-FTIR. Analysis of the IR-
spectrum in the spectral region associated with secondary structure
shows that SP-C33 mainly adopts an α-helical structure, characterized
by an amide I band (1700–1600 cm−1) maximum at 1657 cm−1
(Fig. 1A). Quantiﬁcation of the different secondary structure compo-
nents by deconvolution and curve-ﬁtting of the amide I band
demonstrates that more than 90% of the polypeptide chain forms an
α-helical structure. Upon reconstitution in a lipid bilayer, the SP-
C33M31K, SP-C33M31I, and SP-C30 peptides adopt a similar α-helical
structure as illustrated by the superimposition of their respective amide
I bands (Fig. 1B).
SP-C33 dissolved in methanol or SDS micelles was analyzed by CD
spectroscopy. The resulting spectra (Fig. 2) showed double minima at
208 and 222 nm, typical features for α-helical proteins. Estimation of
the α-helix contents from the residual molar ellipticities at 208 andFig. 1. (A) ATR-FTIR spectrum in the 1800–1500 cm−1 region for SP-C33 in DPPC/PG (
characteristic shape of an α-helical peptide with a maximum at 1657 cm−1. (B) Superimposi
were reconstituted in DPPC/PG (8:2, wt./wt.) lipid environment. The samples in panels A a
subtracted.222 nm yields about 75% helix for SP-C33 in SDS micelles and more
than 90% in methanol.
To determine the orientation of SP-C analogs inserted in a lipid
bilayer, spectra were recordedwith two orthogonal polarizations of the
incident light, parallel (//) and perpendicular (⊥) with respect to the
incident plane as illustrated for SP-C33M31I in Fig. 3 as an example. The
difference spectrum (//–⊥) reports an important positive deviation in
the amide I band region (Fig. 3C). From the dichroic ratios of this band,
the calculated maximum tilts of the long helix axis with respect to a
normal to the crystal surface were 22°, 18°, 18°, and 17° for SP-C33, SP-
C33M31K, SP-C33M31I, and SP-C30, respectively. From the dichroic
ratios of the γw(CH2) band at 1200 cm−1, we have determined that the
maximum tilt between the lipid hydrocarbon chains and a normal to the
germanium surfacewas 25 °. These data demonstrate that the four SP-C
analogs adopt a dominantly transmembrane orientation in a lipid
bilayer.
3.2. H/D exchange of SP-C33 in DPPC/PG
H/D exchange kinetics of SP-C33 reconstituted in a DPPC/PG (8:2,
wt./wt.) lipid bilayer was recorded using ATR-FTIR where the sample
was ﬂushed with D2O at room temperature. After 12 h of deuteration,
55% of the peptide bond protons had not undergone exchange (Fig. 4).
This implies that about half of the helical structure of SP-C33 is rigid
enough to resist exchange of amide hydrogens. No modiﬁcation of the
α-helical structure was observed during the kinetics, indicating that
the secondary structure of SP-C33 is stable.
3.3. In vitro surface activity of SP-C33 and variants thereof
For comparison of the in vitro surface activity of the different
peptides in DPPC/POPG (68:31, wt./wt.), the surface tension during
dynamic conditions was evaluated in the CBS. After the initial
adsorption, quasi-static expansion was performed in which all
preparations showed similar values with no signiﬁcant differences
regardingmaximum andminimum surface tensions after ﬁve pulsation
cycles (Table 1). The medians of the different synthetic preparations
showed γmin around 1–2 mN/m and γmax between 22–27 mN/m. In
addition, the degree of compression required to reach 5 mN/m was
similar (22%–32%) with no signiﬁcant differences between tested
preparations.
3.4. In vivo activity of SP-C33 and variants thereof
In line with the in vitro results, all peptide-containing preparations
behaved similarly in a rabbit model of neonatal RDS. The rabbits were8:2, wt./wt.) lipid environment. The amide I band (1700–1600 cm−1) presents the
tion of SP-C33, SP-C33M31K, SP-C33M31I, and SP-C30 amide I bands. The four peptides
nd B were deuterated during 20 min and the contributions of lateral side chains were
Fig. 2. CD spectra of SP-C33 dissolved in SDS micelles or methanol. The residual molar
ellipticity (θ) is expressed in kdeg×cm2×dmol−1.
Fig. 4. Hydrogen/deuterium exchange kinetics evaluated using ATR-FTIR for SP-C33
reconstituted in DPPC/PG (8:2, wt./wt.). Evolution of the proportion of unexchanged
amide bonds as a function of deuteration time.
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throughout experiments, tidal volumes were very similar in all groups
that received surfactant. After 35 min of ventilation, tidal volumes
around 12–15 ml/kg were observed (Fig. 5). Likewise, the lung gas
volumes measured after the experiments were similar for all
surfactant-treated groups (Fig. 6). For tidal volumes, throughout the
whole experiment, as well as lung gas volumes, all the surfactants
containing peptides were signiﬁcantly better than non-treated
controls but with no signiﬁcant differences between the tested
surfactant preparations.Fig. 3. ATR-FTIR polarized spectra of SP-C33M31I reconstituted in DPPC/PG (8:2, wt./wt.)
lipid environment. The spectra were recorded with parallel (A) and perpendicular
(B) polarized light with respect to the incident plane. (C) The dichroic spectrum obtained
by subtracting (A–B) spectra is expanded twofold in the ordinate direction. The arrows
indicate the protein amide I and the phospholipid γw(CH2) bands.4. Discussion
Investigation of the secondary structure of the SP-C analog SP-C33
using FTIR and CD spectroscopy reveals that the peptide adopts an α-
helical structure when inserted in a DPPC/PG lipid environment, in
SDS micelles and in methanol. The results obtained show that 75%–
90% of the peptide adopts helical conformation. Previous FTIR and CD
studies of native SP-C indicate an α-helical content of 60%–80%
[14,18] while the predecessors to SP-C33, SP-C(Leu) and SP-C(LKS),
show an α-helical content of 84% [19] and 75% [20], respectively. This
indicates that the overall helical contents of native SP-C and analogs
thereof determined by CD and FTIR spectroscopy are similar and in
good agreement with theα-helical content (about 75%) deduced from
the NMR structure of native SP-C dissolved in chloroform/methanol
[21]. We have demonstrated that the three C-terminally modiﬁed
variants of SP-C33 adopt the same conformation as SP-C33 which is
consistent with the fact that all so far analyzed SP-C variants with a
poly-leucine sequence or other synthetic analogs SP-C(CC) and SP-C
(1–21) have very similar helical contents [22].
The orientation of SP-C in lipid membranes have been studied
comprehensively [11,14,18], and in a lipid membrane, native SP-C has
been shown to adopt an orientation where the α-helix is inserted
parallel to the lipid acyl chains. This transmembrane location is
assumed to be an important part of its surfactant activity and is
therefore desirable to include in an analog. By recording FTIR-spectra
with parallel and perpendicular light with respect to the incidence
plane, the transmembrane orientation of SP-C analogs when inserted
in DPPC/PG (8:2, wt./wt.) was conﬁrmed.
In contrast to the propensity of native SP-C to transform from α-
helix to β-sheet in organic solvents, it largely retains its helical
structure when inserted in phospholipids. This is in line with the
observation that membrane embedded valine-rich helix domains are
protected in a hydrophobic environment. Using H/D exchange,
membrane proteins with higher abundance of helix-stabilizing
leucines showed less exchange of amide hydrogen atoms than thoseTable 1
In vitro surface activity of suspensions (10 mg/ml) containing SP-C analogs (2% wt./wt.)
in DPPC/POPG (68:31, wt./wt.) measured in the captive bubble surfactometer.
Peptide in DPPC/POPG (68:31)
n=3 for all preparations
Compression needed to





SP-C33 32 (25–33) 1.1 (1.0–1.6) 27 (26–27)
SP-C30 26 (25–27) 1.8 (1.0–2.7) 22 (18–27)
SP-C33 M31K 32 (20–33) 2.3 (1.9–4.4) 24 (18–25)
SP-C33 M31I 22 (15–33) 0.9 (0.7–1.1) 26 (25–28)
Compression is measured as the difference in bubble area between maximum surface
tension and when surface tension less or equal to 5 mN/m is reached. Presented values
for minimum and maximum surface tensions are from the ﬁfth cycle of quasi-static
dynamics. Values are given as median (range).
Fig. 5. Tidal volumes (VT) in preterm newborn rabbits treated with SP-C analogs in
DPPC/POPG (68:31, wt./wt.) (80 mg/ml, 2.5 ml/kg, n=8 (SP-C33, SP-C30, SP-C33
M31K) or n=7 (SP-C33 M31I)) or non-treated controls (n=7). Values are given as
median. Statistical signiﬁcance: pb0.001 for non-treated controls vs. all other groups at
all time points.
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This would suggest that SP-C33, with a poly-leucine helix, is less
ﬂexible than native SP-C, with a poly-valine helix. In contrast, our
results show a faster H/D exchange with about 60% unexchanged
hydrogens for SP-C33 after 4 h compared to 70%–90% for native
dipalmitoylated SP-C [14,18]. However, after 20 h, the H/D exchange
was rather similar for both SP-C33 and native SP-C with about 55%–
60% unexchanged hydrogens. These results suggest that, while the
presence of a few helix-destabilizing Val or Ile increases ﬂexibility, a
long poly-valine helix like in native SP-C is exceedingly stable. This is
in line with the observation that the SP-C helix is stabilized by a high
activation barrier to unfolding and that, once helix unfolding occurs, it
is not reversible. The presence of peptide bound fatty acyl chains has a
stabilizing effect on conformationally dynamic helices in general [24]
and the palmitoyl groups in SP-C stabilize the helix [25]. It is possible
that the palmitoyl groups linked to SP-C are important for preventing
unfolding of the metastable α-helix in vivo. The helix of SP-C33, in
contrast, is able to unfold and refold and is consequently not
dependent on covalently linked fatty acyl chains for stabilization. In
line with this supposition, palmitoylation of SP-C33 does not result in
alterations of its function [9].Fig. 6. Lung gas volumes after 35 min of ventilation in preterm newborn rabbits treated
with SP-C analogs in DPPC/POPG (68:31, wt./wt.) (80 mg/ml, 2.5 ml/kg) or non-treated
controls. Levels of statistical signiﬁcance: *pb0.001 vs. all other groups. The lines
indicate median values.The effects of modiﬁcations of the C-terminal end of SP-C on
surface activity were investigated using variants of SP-C33. From the
CBS in vitro study, no signiﬁcant differences in surface activity due to
the alterations were noticed. All preparations were equally active with
surface tension shifting from ~25 mN/m to ~1 mN/m at a compression
rate of 25%–30%. There were also no signiﬁcant differences found in
vivo; tidal volumes and lung gas volumes, reﬂecting the functional
residual capacities, were all approximately the same, despite the exact
nature of the C-terminal part. These ﬁndings can be related to reports
on other surfactant protein analogs. It seems that the presence of an
α-helical structure is of greater importance than the primary
structure since exchange of the whole helical sequence of SP-C with
that from bacteriorhodopsin does not inﬂuence the surface activity in
vitro [22]. In the same study, it was shown that the length of the helix
was of importance since truncation of the native SP-C sequence at
residues 12, 17, or 21 noticeably decreased surface activities, while in
our study, SP-C30 showed no variance compared to the longer
peptides. This implies that an α-helical peptide that is able to span at
least the nonpolar parts of a phospholipid membrane is necessary for
activity of a synthetic surfactant. The importance of the helical length
for surface activity has also been shown in a study using peptoid SP-C
mimics. Here, it was shown that a helical length of approximately 28 Å
was superior in comparison with peptoids containing shorter helices
[26].
Earlier studies show surfactant activity of SP-C33 to be similar to
the activity of native SP-C. Both in vivo and in vitro data of the
modiﬁed peptides in this study, in comparison to SP-C33, thus suggest
that all the studied analogs are similarly efﬁcient regarding surfactant
activity as native SP-C and could therefore be used as a functional
analog in a synthetic surfactant.Acknowledgments
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